Study to Examine the Effects of Oral Fenretinide
Clinical trial NCT06528457 · COMPLETED
Trial details
- NCT number
- NCT06528457
- Sponsor
- Island Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-05
- Primary completion
- 2025-05-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.